Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 5/20 | 1.00 |
| ▸ | CTSB | P07858 | 5/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.78 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.78 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.78 |
| ▸ | MAOB | P27338 | 1/20 | 0.74 |
| ▸ | DPP4 | P27487 | 3/20 | 0.71 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.69 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.69 |
| ▸ | APP | P05067 | 1/20 | 0.68 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.68 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Echinatin SCHEMBL29466900 | 1.00 | CTSL (1.00) | CTSLCTSBTDP1CAPN1CYP1A1 | |
| Echinatin SCHEMBL7193984 | 1.00 | CTSL (1.00) | CTSLCTSBTDP1CAPN1CYP1A1 | |
| SCHEMBL26113846 | 0.93 | CTSB (0.86) | CTSLCTSBTDP1CAPN1CYP1A1 | |
| SCHEMBL20340332 | 0.91 | CTSL (0.84) | CTSLCTSBTDP1CAPN1CYP1A1 | |
| SCHEMBL20340331 | 0.91 | CTSL (0.84) | CTSLCTSBTDP1CAPN1CYP1A1 | |
| SCHEMBL7180313 | 0.90 | TNFRSF1A (0.86) | CTSLCTSBTDP1CAPN1CYP1A1 | |
| SCHEMBL7180309 | 0.90 | TNFRSF1A (0.86) | CTSLCTSBTDP1CAPN1CYP1A1 | |
| SCHEMBL29600833 | 0.90 | TNFRSF1A (0.86) | CTSLCTSBTDP1CAPN1CYP1A1 | |
| SCHEMBL8964952 | 0.85 | MAOB (1.00) | CTSLCTSBTDP1CAPN1CYP1A1 | |
| SCHEMBL29403206 | 0.85 | MAOB (1.00) | CTSLCTSBTDP1CAPN1CYP1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| EP-2603098-B1 | METHOD OF IMPROVING STABILITY OF SWEET ENHANCER AND COMPOSITION CONTAINING STABILIZED SWEET ENHANCER | FIRMENICH INCORPORATED (US) | 2025-08-06 | — | — | EP | claimed |
| CN-118813576-B | Protein coded by safflower CtHA gene and application thereof | 新疆农业科学院经济作物研究所(新疆维吾尔自治区棉花研究所新疆维吾尔自治区甜菜改良中心) | 2025-04-04 | — | — | CN | claimed |
| WO-2024258363-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | SAHIN FIKRET (TR) | 2024-12-19 | — | — | WO | claimed |
| US-20240360485-A1 | PROCESS FOR PREPARATION OF PHLOROGLUCINOL AND PHENOLIC DERIVATIVES | EHRHARDT JEFFREY (US) | 2024-10-31 | — | — | US | claimed |
| CN-118813576-A | Protein coded by safflower CtHA gene and application thereof | 新疆农业科学院经济作物研究所(新疆维吾尔自治区棉花研究所新疆维吾尔自治区甜菜改良中心) | 2024-10-22 | — | — | CN | claimed |
| US-20240285660-A1 | COMPOSITION FOR WOUND RELIEF AND INHIBITING A PHD PROTEIN AND METHODS OF TREATMENT | CURAPEP LLC (US) | 2024-08-29 | — | — | US | claimed |
| CN-118356431-A | Pharmaceutical composition for preventing or treating inflammatory bowel disease, preparation and application thereof | 沈阳药科大学 | 2024-07-19 | — | — | CN | claimed |
| US-20230012268-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION WITH STEROIDS AND A MODULATOR | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2023-01-12 | — | — | US | claimed |
| WO-2022232243-A1 | COMPOSITIONS FOR WOUND RELIEF AND INHIBITING A PHD PROTEIN AND METHODS OF TREATMENT | CURAPEP LLC (US) | 2022-11-03 | — | — | WO | claimed |
| WO-2012021837-A2 | METHOD OF IMPROVING STABILITY OF SWEET ENHANCER AND COMPOSITION CONTAINING STABILIZED SWEET ENHANCER | SENOMYX, INC. (US) | 2012-02-16 | — | — | WO | claimed |
| CN-101596227-A | A kind of Chinese herbal and crude drugs preparations for the treatment of advanced lung cancer | YIN LIAO (CN) | 2009-12-09 | — | — | CN | claimed |
| CN-101069563-A | Beverage composition and method for preventing degradation of vitamins in beverages | PEPSICO INC (US) | 2007-11-14 | — | — | CN | claimed |
| US-20070110851-A1 | Beverage composition and method of preventing degradation of vitamins in beverages | PEPSICO, INC. | 2007-05-17 | — | — | US | claimed |
| EP-1782701-A1 | Beverage composition and method of preventing degradation of vitamins in beverages | PepsiCo, Inc. (US) | 2007-05-09 | — | — | EP | claimed |
| CN-1599602-A | Peroxisome proliferator activated receptor ligands and process for producing the same | KANEGAFUCHI CHEMICAL IND (JP) | 2005-03-23 | — | — | CN | claimed |
| US-20050014819-A1 | Peroxisome proliferator activated receptor ligands and process for producing the same | KANEKA CORPORATION (JP) | 2005-01-20 | — | — | US | claimed |
| EP-1440688-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGANDS AND PROCESS FOR PRODUCING THE SAME | KANEKA CORPORATION (JP) | 2004-07-28 | — | — | EP | claimed |
| US-20040091589-A1 | Prevention of synthetic color fading in beverages using botanically derived color stabilizers | PEPSICO, INC. | 2004-05-13 | — | — | US | claimed |
| EP-0998939-A1 | Chalcone plant extracts for use in therapy | THE SCHOOL OF PHARMACY, UNIVERSITY OF LONDON (GB) | 2000-05-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014819-A1 | Peroxisome proliferator activated receptor ligands and process for producing the same | PPARG, PPARA, PPARD | CTSL 3528/4885CTSB 4149/4885TDP1 4857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.